Published in Hepatitis Weekly, August 16th, 2010
"Modification of the ester and amino acid moieties lead to a compound INX-08189 that exhibits 10nM potency in the HCV...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2010-08-16)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.